| Significance of YAP1-MAML2 rearrangement and GTF2I mutation in the diagnosis and differential diagnosis of metaplastic thymoma. | Significance of YAP1-MAML2 rearrangement and GTF2I mutation in the diagnosis and differential diagnosis of metaplastic thymoma.
Wang M, Xu H, Han Q, Wang L., Free PMC Article | 09/8/2023 |
| Pathogenic variations in MAML2 and MAMLD1 contribute to congenital hypothyroidism due to dyshormonogenesis by regulating the Notch signalling pathway. | Pathogenic variations in MAML2 and MAMLD1 contribute to congenital hypothyroidism due to dyshormonogenesis by regulating the Notch signalling pathway.
Wu FY, Yang RM, Zhang HY, Zhan M, Tu PH, Fang Y, Zhang CX, Song SY, Dong M, Cui RJ, Liu XY, Yang L, Yan CY, Sun F, Zhang RJ, Wang Z, Liang J, Song HD, Cheng F, Zhao SX. | 08/23/2023 |
| Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity. | Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity.
Dermawan JK, DiNapoli SE, Sukhadia P, Mullaney KA, Gladdy R, Healey JH, Agaimy A, Cleven AH, Suurmeijer AJH, Dickson BC, Antonescu CR., Free PMC Article | 02/14/2023 |
| Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens. | Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens.
Yamanaka S, Suzuki S, Ito H, Sivasundaram K, Hanamura I, Okubo I, Yoshikawa K, Ono S, Takahara T, Satou A, Tsuzuki T, Ueda R, Ogawa T, Fujimoto Y., Free PMC Article | 02/4/2023 |
| Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2- rearranged salivary gland tumours. | Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2- rearranged salivary gland tumours.
Bishop JA, Thompson LDR, Siegele B, Gagan J, Mansour M, Chernock RD, Rooper LM. | 12/17/2022 |
| MAML2 Gene Rearrangement Occurs in Nearly All Hidradenomas: A Reappraisal in a Series of 20 Cases. | MAML2 Gene Rearrangement Occurs in Nearly All Hidradenomas: A Reappraisal in a Series of 20 Cases.
Russell-Goldman E, Hanna J. | 10/22/2022 |
| Recurrent YAP1::MAML2 fusions in ""nodular necrotizing"" variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases. | Recurrent YAP1::MAML2 fusions in "nodular necrotizing" variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases.
Perret R, Tallegas M, Velasco V, Soubeyran I, Coindre JM, Azmani R, Baud J, Bacle G, De Pinieux G, Le Loarer F. | 10/8/2022 |
| Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma. | Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma.
Thierauf JC, Farahani AA, Indave BI, Bard AZ, White VA, Smith CR, Marble H, Hyrcza MD, Chan JKC, Bishop J, Shi Q, Ely K, Agaimy A, Martinez-Lage M, Nose V, Rivera M, Nardi V, Dias-Santagata D, Garg S, Sadow P, Le LP, Faquin W, Ritterhouse LL, Cree IA, Iafrate AJ, Lennerz JK., Free PMC Article | 04/30/2022 |
| Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features. | Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
Nakano S, Okumura Y, Murase T, Nagao T, Kusafuka K, Urano M, Yamamoto H, Kano S, Tsukahara K, Okami K, Kawakita D, Nagao T, Hanai N, Iwai H, Kawata R, Tada Y, Nibu KI, Inagaki H. | 04/2/2022 |
| KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up. | KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.
Felix CA, Slater DJ, Davenport JW, Yu X, Gregory BD, Li MM, Rappaport EF, Cheung NV., Free PMC Article | 03/5/2022 |
| Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma. | Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.
Ni W, Chen Z, Zhou X, Yang R, Yu M, Lu J, Kaye FJ, Wu L., Free PMC Article | 03/5/2022 |
| The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma. | The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
Chen Z, Ni W, Li JL, Lin S, Zhou X, Sun Y, Li JW, Leon ME, Hurtado MD, Zolotukhin S, Liu C, Lu J, Griffin JD, Kaye FJ, Wu L., Free PMC Article | 01/22/2022 |
| [MAML2 gene rearrangement, fusion patterns and clinicopathological characteristics in primary pulmonary mucoepidermoid carcinoma]. | [MAML2 gene rearrangement, fusion patterns and clinicopathological characteristics in primary pulmonary mucoepidermoid carcinoma].
Zhang X, Bai QM, Yao QL, Ji G, Chang H, Han J, Li Y, Ji Y, Hou YY, Zhou XY. | 09/18/2021 |
| Reevaluation of Salivary Lymphadenoma: A Subgroup Identified as Warthin-like Mucoepidermoid Carcinoma Following Molecular Investigation for MAML2 Rearrangement. | Reevaluation of Salivary Lymphadenoma: A Subgroup Identified as Warthin-like Mucoepidermoid Carcinoma Following Molecular Investigation for MAML2 Rearrangement.
Zhang C, Gu T, Hu Y, Sun J, Xia R, Tian Z, Wang L, Li J. | 08/14/2021 |
| Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features. | Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features.
Tamai S, Nakano Y, Kinoshita M, Sabit H, Nobusawa S, Arai Y, Hama N, Totoki Y, Shibata T, Ichimura K, Nakada M. | 07/24/2021 |
| Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions. | Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.
Vivero M, Davineni P, Nardi V, Chan JKC, Sholl LM. | 02/2/2021 |
| Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma. | Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma.
Antonescu CR, Dickson BC, Sung YS, Zhang L, Suurmeijer AJH, Stenzinger A, Mechtersheimer G, Fletcher CDM., Free PMC Article | 01/16/2021 |
| MAML2 rearrangement as a useful diagnostic marker discriminating between Warthin tumour and Warthin-like mucoepidermoid carcinoma. | MAML2 rearrangement as a useful diagnostic marker discriminating between Warthin tumour and Warthin-like mucoepidermoid carcinoma.
Bieńkowski M, Kunc M, Iliszko M, Kuźniacka A, Studniarek M, Biernat W., Free PMC Article | 09/19/2020 |
| MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis. | MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis.
Kim J, Kwon H, Shin YK, Song G, Lee T, Kim Y, Jeong W, Lee U, Zhang X, Nam G, Jeung HC, Kim W, Jho EH., Free PMC Article | 09/19/2020 |
| Effects of the MAML2 genetic variants in glioma susceptibility and prognosis. | Effects of the MAML2 genetic variants in glioma susceptibility and prognosis.
Zhang M, Zhao Y, Zhao J, Huang T, Guo X, Ma X, Wu Y., Free PMC Article | 09/19/2020 |
| The absence of MAML2 rearrangement reveals that ameloblastoma with mucous cell differentiation and central mucoepidermoid carcinoma are two distinct tumor entities. | Ameloblastoma with mucous cells: A clinicopathological, BRAF mutation, and MAML2 rearrangement study.
Xia RH, Zhang CY, Sun JJ, Tian Z, Hu YH, Gu T, Wang LZ, Li J. | 08/1/2020 |
| YAP1-MAML2 and YAP1-NUTM1 fusions have roles in poroma and porocarcinoma | Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
Sekine S, Kiyono T, Ryo E, Ogawa R, Wakai S, Ichikawa H, Suzuki K, Arai S, Tsuta K, Ishida M, Sasajima Y, Goshima N, Yamazaki N, Mori T., Free PMC Article | 06/27/2020 |
| The rs7944701 SNP in MAML2 was strongly associated with bladder cancer susceptibility in a Chinese population. MAML2 expression was lower in bladder cancer tissues than in non-tumor tissues and bladder cancer patients with high MAML2 expression had a significantly poorer prognosis. | Genetic variant of MAML2 in the NOTCH signaling pathway and the risk of bladder cancer: A STROBE-compliant study.
Shen Y, Lu Q, Ye H, Deng Z, Ma L, Zhang Q, Tang J, Yuan L., Free PMC Article | 03/7/2020 |
| The associations of PSEN1 rs165934 and MAML2 rs76032516 of the Notch signalling pathway genes with overall survival in Chinese epithelial ovarian cancer patients are novel findings, which need to be validated in other large and independent studies. | Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer.
Xu Y, Cheng L, Dai H, Zhang R, Wang M, Shi T, Sun M, Cheng X, Wei Q., Free PMC Article | 11/23/2019 |
| Pancreatic mucoepidermoid carcinoma does not have CRTC1/3-MAML2 fusion gene and MAML2 gene rearrangement. | "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
Saeki K, Ohishi Y, Matsuda R, Mochidome N, Miyasaka Y, Yamamoto H, Koga Y, Maehara Y, Nakamura M, Oda Y. | 09/7/2019 |